Postbiotics as potential new therapeutic agents for sepsis
Open accessThe DOI matches its Crossref record; 137 of the 140 references it cites were found in a registry or an index.
Abstract
Sepsis is the main cause of death in critically ill patients and gut microbiota dysbiosis plays a crucial role in sepsis. On the one hand, sepsis leads to the destruction of gut microbiota and induces and aggravates terminal organ dysfunction. On the other hand, the activation of pathogenic gut flora and the reduction in beneficial microbial products increase the susceptibility of the host to sepsis. Although probiotics or fecal microbiota transplantation preserve gut barrier function on multiple levels, their efficacy in sepsis with intestinal microbiota disruptions remains uncertain. Postbiotics consist of inactivated microbial cells or cell components. They possess antimicrobial, immunomodulatory, antioxidant and antiproliferative activities. Microbiota-targeted therapy strategies, such as postbiotics, may reduce the incidence of sepsis and improve the prognosis of patients with sepsis by regulating gut microbial metabolites, improving intestinal barrier integrity and changing the composition of the gut microbiota. They offer a variety of mechanisms and might even be superior to more conventional ‘biotics’ such as probiotics and prebiotics. In this review, we present an overview of the concept of postbiotics and summarize what is currently known about postbiotics and their prospective utility in sepsis therapy. Overall, postbiotics show promise as a viable adjunctive therapy option for sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Sepsis and gut microbiota form a bidirectional vicious cycle.”
From Progress on the correlation between sepsis and gut microbiota: a narrative review (2026) · cites this paper as Lou et al., 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Fleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548 · cited 1×
“Globally, there are >19 million cases of severe sepsis each year, leading to at least 5 million deaths [7].”
BackgroundRinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 2×
“They help the body obtain energy from meals and decompose indigestible carbohydrates and proteins, digest and absorb nutrients, synthesize vitamins and promote host immunity [2].”
BackgroundSalminen, S., Collado, M. C., Endo, A., Hill, C., Lebeer, S., Quigley, E. M. M., Sanders, M. E., Shamir, R., Swann, J. R., Szajewska, H., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00440-6 · Cited by 2,488
The role of short chain fatty acids in health and disease
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425 · cited 1×
“SCFAs may play a key role in regulating inflammatory diseases by controlling the movement of immune cells to sites of inflammation, regulating the activity of immune cells and allowing the number of pathogens to decrease quickly [80].”
BackgroundEffects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401 · cited 1×
“Supplementation with high-quality probiotics, prebiotics and synbiotics can fight pathogenic bacteria and maintain the stability of gut flora, consequently increasing immune function and reducing disease incidence [29].”
Background
Research works printed but not linked: 1
- Yang, 2022, Exploration
Cited by
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy
Piccioni, A., Spagnuolo, F., Candelli, M., Voza, A., Covino, M., Gasbarrini, A., & Franceschi, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206082 · Cited by 63
Torres, J. S. S., Tamayo-Giraldo, F. J., Zuleta, A., Nati-Castillo, H. A., Quintero, D. A., Ospina-Mejía, M. J., Salazar-Santoliva, C., Suárez-Sangucho, I. A., Ortiz‐Prado, E., & Izquierdo‐Condoy, J. S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1560737 · Cited by 63
Głowacka, P., Oszajca, K., Pudlarz, A. M., Szemraj, J., & Witusik‐Perkowska, M. (2024) · Nutrients · doi:10.3390/nu16142244 · Cited by 60
Petakh, P., Duve, K. V., Oksenych, V., Behzadi, P., & Kamyshnyi, O. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1394953 · Cited by 51
Postbiotics as Adjuvant Therapy in Cancer Care
Balendra, V., Rosenfeld, R., Amoroso, C., Castagnone, C., Rossino, M. G., Garrone, O., & Ghidini, M. (2024) · Nutrients · doi:10.3390/nu16152400 · Cited by 46
Metadata
- Authors
- Lou, X., Xue, J., Shao, R., Mo, C., Wang, F., & Chen, G.
- Affiliations
- Kunming University of Science and Technology (CN)
- First People's Hospital of Yunnan Province (CN)
- Corresponding author
- Chen, Guobing
- Venue
- Burns & Trauma
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-01-01
- Volume
- 11
- Pages
- tkad022-tkad022
- ISSN
- 2321-3868 (ISSN-L)
- 2321-3876
- PMC
- PMC10271603
- OpenAlex
- W4380854547
- Semantic Scholar
- fd9c9eaa32b28dcc75efb8bec0fb287eba2995d3
- Cited by
- 38
- References
- 140
- Citations by year
- 2026: 14 · 2025: 9 · 2024: 13 · 2023: 2
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Burns & Trauma (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82160366)
- Yunnan Young and Middle-aged Academic and Technical Leaders Reserve Talent Project (C098-2060499)
- Yunnan Clinical Medical Center Open Project (2021LCZXXF-HX03)
- Yunnan Key Laboratory of Stomatology Open Project (2022YNKQ004)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- postbiotics, sepsis, gut dysbiosis, intestinal barrier integrity, microbiota-targeted therapy, probiotics, prebiotics, gut microbiota metabolites, immunomodulation, adjunctive therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postbiotics as potential new therapeutic agents for sepsis. https://app.cochat.ai/papers/10.1093/burnst/tkad022
- The paper
- Lou, X., Xue, J., Shao, R., Mo, C., Wang, F., & Chen, G. (2023). Postbiotics as potential new therapeutic agents for sepsis. Burns & Trauma. https://doi.org/10.1093/burnst/tkad022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.